| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |